A novel factor V mutation causes a normal activated protein C ratio despite the presence of a heterozygous F5 R506Q (factor V Leiden) mutation. [electronic resource]

By:

Prüller, Florian

Contributor(s):

Raggam, Reinhard B
Mangge, Harald
Truschnig-Wilders, Martie
Matzhold, Eva-Maria
Weiss, Eva-Christine
Hasiba, Barbara
Summers, Kelli L
Renner, Wilfried
Siegert, Gabriele
Kostka, Heike

Producer: 20131203Description: 414-7 p. digitalISSN:

1365-2141

Subject(s):

Activated Protein C Resistance -- genetics
Adolescent
Amino Acid Substitution
Asymptomatic Diseases
Blood Coagulation Tests
Enzyme Activation -- genetics
Factor V -- chemistry
Female
Heterozygote
Humans
Male
Molecular Sequence Data
Mutation, Missense
Pedigree
Point Mutation
Protein C -- analysis
Protein Stability
Protein Structure, Tertiary
Thrombophilia -- genetics

Online resources:

Available from publisher's website

In: British journal of haematology vol. 163

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Letter

There are no comments on this title.

Browse results Close

Back to results

1 Bromoallenes as allyl dication equivalents in the absence of palladium(0): synthesis of bicyclic sulfamides by tandem cyclization of bromoallenes.
by Hamaguchi, Hisao
2 Bromoallenes as synthetic equivalents of allyl dications: synthesis of medium-sized nitrogen heterocycles through the cyclization of bromoallenes in the presence of a palladium(0) catalyst and an alcohol.
by Ohno, Hiroaki
3 A highly cis-selective synthesis of 2-ethynylaziridines by intramolecular amination of chiral bromoallenes: improvement of stereoselectivity based on the computational investigation.
by Ohno, Hiroaki
4 Palladium(0)-catalyzed synthesis of medium-sized heterocycles by using bromoallenes as an allyl dication equivalent.
by Ohno, Hiroaki
5 Bromoallenes as allyl dication equivalents in the presence or absence of palladium(0): direct construction of bicyclic sulfamides containing five- to eight-membered rings by tandem cyclization of bromoallenes.
by Hamaguchi, Hisao
6 Palladium(0)-catalyzed tandem cyclization of allenenes: direct construction of tricyclic heterocycles through aromatic C--H activation.
by Ohno, Hiroaki
7 Novel quinuclidinyl heteroarylcarbamate derivatives as muscarinic receptor antagonists.
by Nagashima, Shinya
8 Discovery and structural characterization of peficitinib (ASP015K) as a novel and potent JAK inhibitor.
by Hamaguchi, Hisao
9 Discovery of 3,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-2(1H)-one derivatives as novel JAK inhibitors.
by Yamagishi, Hiroaki
10 Synthesis and evaluation of 1H-pyrrolo[2,3-b]pyridine derivatives as novel immunomodulators targeting Janus kinase 3.
by Nakajima, Yutaka
11 Corrigendum to "Synthesis and evaluation of novel 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives as potent and orally efficacious immunomodulators targeting JAK3" [Bioorg. Med. Chem. 23 (2015) 4871-4883].
by Nakajima, Yutaka
12 Corrigendum to "Synthesis and evaluation of novel 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives as potent and orally efficacious immunomodulators targeting JAK3" [Bioorg. Med. Chem. 23 (2015) 4871-4883].
by Nakajima, Yutaka
13 Synthesis and evaluation of novel 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives as potent and orally efficacious immunomodulators targeting JAK3.
by Nakajima, Yutaka

A novel factor V mutation causes a normal activated protein C ratio despite the presence of a heterozygous F5 R506Q (factor V Leiden) mutation.

APA

Prüller F., Raggam R. B., Mangge H., Truschnig-Wilders M., Matzhold E., Weiss E., Hasiba B., Summers K. L., Renner W., Siegert G. & Kostka H. (20131203). A novel factor V mutation causes a normal activated protein C ratio despite the presence of a heterozygous F5 R506Q (factor V Leiden) mutation. : British journal of haematology.

Chicago

Prüller Florian, Raggam Reinhard B, Mangge Harald, Truschnig-Wilders Martie, Matzhold Eva-Maria, Weiss Eva-Christine, Hasiba Barbara, Summers Kelli L, Renner Wilfried, Siegert Gabriele and Kostka Heike. 20131203. A novel factor V mutation causes a normal activated protein C ratio despite the presence of a heterozygous F5 R506Q (factor V Leiden) mutation. : British journal of haematology.

Harvard

Prüller F., Raggam R. B., Mangge H., Truschnig-Wilders M., Matzhold E., Weiss E., Hasiba B., Summers K. L., Renner W., Siegert G. and Kostka H. (20131203). A novel factor V mutation causes a normal activated protein C ratio despite the presence of a heterozygous F5 R506Q (factor V Leiden) mutation. : British journal of haematology.

MLA

Prüller Florian, Raggam Reinhard B, Mangge Harald, Truschnig-Wilders Martie, Matzhold Eva-Maria, Weiss Eva-Christine, Hasiba Barbara, Summers Kelli L, Renner Wilfried, Siegert Gabriele and Kostka Heike. A novel factor V mutation causes a normal activated protein C ratio despite the presence of a heterozygous F5 R506Q (factor V Leiden) mutation. : British journal of haematology. 20131203.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC